Skip to main content

Durable responses at ≥12 months with zola-cel in severe refractory systemic lupus erythematosus: safety, efficacy, and translational findings from the full phase 1 Breakfree-1 cohort

File

ADD THE FIRST COMMENT

If you are a health practitioner, you may to comment.

Due to the nature of these comment forums, only health practitioners are allowed to comment at this time.

×